Kumari, P.; Tarighi, S.; Fuchshuber, E.; Li, L.; Fernandez-Duran, I.; Wang, M.; Ayoson, J.; Castello-Garcia, J. M.; Gamez-Garcia, A.; Espinosa-Alcantud, M.et al.; Sreenivasan, K.; Guenther, S.; Olivella, M.; Savai, R.; Yue, S.; Vaquero, A.; Braun, T.; Ianni, A.: SIRT7 promotes lung cancer progression by destabilizing the tumor suppressor ARF. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 121 (25), e2409269121 (2024)
Vazquez, B. N.; Fernandez-Duran, I.; Hernandez, Y.; Tarighi, S.; Thackray, J. K.; Espinosa-Alcantud, M.; Kumari, P.; Ianni, A.; Cesaire, L.; Braun, T.et al.; Esteller, M.; Tischfield, J.; Vaquero, A.; Serrano, L.: SIRT7 and p53 interaction in embryonic development and tumorigenesis. FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY 11, 1281730 (2024)
Researchers at the Max Planck Institute develop a new pharmacological approach that specifically targets receptor interactions – with implications for immune defense and blood pressure regulation
A team of researchers at the Max Planck Institute for Heart and Lung Research, led by Prof. Dr. Didier Y.R. Stainier, has been awarded a prestigious ERC Proof of Concept (PoC) grant to advance a groundbreaking RNA-based therapeutic strategy for Duchenne Muscular Dystrophy (DMD).